Send the following on WhatsApp
Continue to Chat08.06.2022BioVersys AG announces successful first closing of CHF 24.2 million Series C financing to develop clinical pipeline of novel AMR... https://techparkbasel.ch/news-details/bioversys-announces-chf-24-2-million-financing.html